Attached files
| file | filename |
|---|---|
| EX-32.2 - Brooklyn ImmunoTherapeutics, Inc. | ex32-2.htm |
| EX-32.1 - Brooklyn ImmunoTherapeutics, Inc. | ex32-1.htm |
| EX-31.2 - Brooklyn ImmunoTherapeutics, Inc. | ex31-2.htm |
| EX-31.1 - Brooklyn ImmunoTherapeutics, Inc. | ex31-1.htm |
| EX-23.1 - Brooklyn ImmunoTherapeutics, Inc. | ex23-1.htm |
| EX-10.13 - Brooklyn ImmunoTherapeutics, Inc. | ex10-13.htm |
| 10-K - Brooklyn ImmunoTherapeutics, Inc. | form10-k.htm |
EXHIBIT 21.1
SUBSIDIARIES OF THE REGISTRANT
Subsidiary |
State Or Country Of Organization | |
| NTN Canada, Inc. | Canada |
*Pursuant to Item 601(b)(21)(ii) of Regulation S-K, the names of other subsidiaries of the registrant are omitted because, considered in the aggregate, they would not constitute a significant subsidiary as of the end of the year covered by this report.